Plaque Modification Devices Market Revenue & Forecast Analysis, 2026-2035

The global plaque modification devices market was estimated at USD 2,190.38 million in 2025 and is expected to grow at a CAGR of 8.6% from USD 2,361.23 million to USD 4,981.66 million in 2035. The plaque modification devices market is experiencing consistent expansion, fueled by the rising incidence of atherosclerotic cardiovascular disorders, the escalating burden of coronary artery disease, and the increasing use of sophisticated minimally invasive cardiovascular procedures. Moreover, the growth of cardiac catheterisation labs, escalating healthcare spending, and heightened awareness of early management of cardiovascular diseases are driving market expansion.

Published: July 13, 2026
100 Pages

Market Overview

The Centers for Disease Control and Prevention (CDC) indicate that almost 50% of adults 30 years and older in the United States exhibit symptoms of periodontal disease, heightening the need for efficient plaque management options and preventive dental care.

The plaque modification devices market has experienced consistent growth over the past decade, fueled by the increasing prevalence of coronary artery disease (CAD), a higher occurrence of heavily calcified coronary lesions, and a greater adoption of advanced percutaneous coronary intervention (PCI) techniques. The market has gained from ongoing progress in atherectomy technologies, intravascular lithotripsy (IVL), and lesion preparation devices, enhancing treatment results for complicated cardiovascular cases. In 2021, Shockwave Medical obtained expanded FDA approvals for its Shockwave C2 Coronary IVL System, hastening the use of calcium modification technology for addressing severely calcified coronary lesions in American patients undergoing PCI procedures.

The plaque modification devices market is projected to witness strong growth over the forecast period, driven by the escalating prevalence of cardiovascular diseases, an aging demographic, heightened demand for minimally invasive cardiac procedures, and ongoing advancements in plaque modification technologies. Increasing use of advanced atherectomy systems, enhanced integration of intravascular imaging, and the growth of cardiac catheterisation labs are projected to boost market expansion. For instance, by 2035, innovative plaque modification technologies like next-gen intravascular lithotripsy systems, AI-driven lesion evaluation tools, and enhanced atherectomy devices are expected to see broader use in cardiac centers, facilitating safer management of intricate calcified lesions and boosting PCI success rates.

Plaque Modification Devices Market Overview

Base Year Market Size (2025): USD 2,190.38 Million

CAGR: 8.6%

Forecast Year Market Size (2035): USD 4,981.66 Million

Leading Region: North America

Emerging Countries: China, India, Brazil, South Korea, United Arab Emirates (UAE)

Major Players:

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Cardiovascular Systems, Inc. (Abbott)

  • Medtronic plc

  • Shockwave Medical, Inc. (Johnson & Johnson)

Plaque Modification Devices Market Trends

The plaque modification devices market is experiencing swift progress, propelled by the rising occurrence of intricate calcified coronary lesions, an escalating demand for minimally invasive cardiovascular techniques, and ongoing advancements in lesion preparation technologies.

  • A major trend is the increasing use of intravascular lithotripsy (IVL) for addressing heavily calcified lesions in coronary and peripheral arteries. IVL technology is increasingly being embraced as it can break apart vascular calcium with reduced vessel damage and enhance stent expansion.

  • Manufacturers are placing greater emphasis on advanced lesion preparation devices, such as specialised balloons and hybrid plaque modification technologies, aimed at boosting procedural safety, minimising complications, and improving long-term clinical results.

  • The market is witnessing a growing adoption of sophisticated atherectomy systems, such as rotational, orbital, and directional atherectomy devices, which are commonly employed to alter calcified plaque before stent placement and enhance procedural outcomes in challenging PCI.

  • Additionally, there is an increasing movement towards interventions guided by intravascular imaging, incorporating technologies like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in plaque modification techniques to enhance lesion evaluation, choice of devices, and treatment results.

Collectively, the rising use of intravascular lithotripsy, ongoing advancements in atherectomy technologies, and heightened demand for image-guided minimally invasive cardiovascular interventions are significant elements influencing the future expansion of the plaque modification devices market.

Plaque Modification Devices Market Analysis

By Product Type

Atherectomy devices dominate the plaque modification devices market due to their proven effectiveness in treating heavily calcified arterial lesions and improving outcomes during complex coronary interventions

Based on product type, the plaque modification devices market is categorised into atherectomy devices, thrombectomy devices, chronic total occlusion (CTO) devices, and embolic protection devices. The atherectomy devices segment holds the largest market share of 48.89% in 2025.

By Application

Coronary artery disease dominates the plaque modification devices market due to the high global burden of cardiovascular disease and the increasing volume of complex coronary interventions.

Based on application, the plaque modification devices market is categorised into coronary artery disease and peripheral artery disease. The coronary artery disease segment holds the largest market share in 2025.

By End-use

Hospitals dominate the plaque modification devices market due to the high volume of complex cardiovascular procedures and the availability of advanced cardiac catheterisation laboratories.

Based on end-use, the plaque modification devices market is categorised into hospitals, ambulatory surgical centers, specialty centers, and others. The hospitals segment holds the largest market share in 2025.

Regional Analysis

North America dominates the plaque modification devices market due to the high prevalence of cardiovascular diseases, advanced interventional cardiology infrastructure, and rapid adoption of innovative plaque modification technologies

North America holds the largest share (43.12%) of the plaque modification devices market in 2025.

Europe is emerging as a key market for plaque modification devices due to rising cardiovascular disease burden, expanding adoption of minimally invasive interventions, and increasing investments in advanced cardiac care

Europe is anticipated to experience substantial growth in the plaque modification devices market throughout the forecast period, driven by the rising incidence of calcified coronary artery disease, heightened awareness of advanced lesion preparation methods, and a growing number of specialised cardiac centers.

Key Companies Profiled

The plaque modification devices market is moderately consolidated, with major cardiovascular device producers holding a substantial portion of the global market due to ongoing advancements in atherectomy systems, intravascular lithotripsy (IVL), and enhanced lesion preparation technologies. Market competition is mainly influenced by product development, clinical effectiveness, procedural safety, and increasing acceptance of minimally invasive cardiovascular procedures.

Key companies like Abbott Laboratories, Boston Scientific Corporation, Cardiovascular Systems, Inc. (Abbott), Medtronic plc, and Shockwave Medical, Inc. (Johnson & Johnson) together command a significant portion of the global market, bolstered by their wide-ranging cardiovascular offerings, robust research and development expertise, and broad footprint in hospitals and cardiac catheterisation labs globally.

The competitive environment is additionally influenced by the growing use of intravascular lithotripsy, rotational and orbital atherectomy devices, along with image-guided plaque alteration techniques for addressing intricate calcified coronary and peripheral artery lesions. Ongoing investments in advanced cardiovascular technologies, targeted acquisitions, and the enhancement of interventional cardiology product ranges are anticipated to bolster the market presence of top manufacturers throughout the forecast period.

Plaque Modification Devices Market Companies:

  • Abbott Laboratories

  • Acotec Scientific Holdings Limited

  • Asahi Intecc Co., Ltd.

  • BIOTRONIK SE & Co. KG

  • Boston Scientific Corporation

  • Cardiovascular Systems, Inc. (Abbott)

  • C. R. Bard, Inc. (BD)

  • Koninklijke Philips N.V.

  • Medtronic plc

  • Merit Medical Systems, Inc.

  • Penumbra, Inc.

  • Shockwave Medical, Inc. (Johnson & Johnson)

  • Straub Medical AG

  • Terumo Corporation

  • Teleflex Incorporated

  • W. L. Gore & Associates, Inc.

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the plaque modification devices market by-

Product Type (Revenue in USD Million, 2021 - 2035)

  • Atherectomy Devices

  • Thrombectomy Devices

  • Chronic Total Occlusion Devices

  • Embolic Protection Devices

Application (Revenue in USD Million, 2021 - 2035)

  • Coronary Artery Disease

  • Peripheral Artery Disease

End-use (Revenue in USD Million, 2021 – 2035)

  • Hospitals

  • Ambulatory Surgical Centers

  • Specialty Centers

  • Others

Regional (Revenue in USD Million, 2021 - 2035)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Switzerland

    • Netherlands

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

    • Indonesia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Atherectomy Devices

4.2. Thrombectomy Devices

4.3. Chronic Total Occlusion Devices

4.4. Embolic Protection Devices

5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

5.1. Coronary Artery Disease

5.2. Peripheral Artery Disease

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Ambulatory Surgical Centers

6.3. Specialty Centers

6.4. Others

7. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

7.1. North America

7.1.1. U.S.

7.1.1.1. U.S. Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

7.1.2. Canada

7.1.2.1. Canada Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.2.2. Market Dynamics

7.1.2.3. Competitive Landscape

7.1.2.4. Regulatory Framework

7.1.2.5. Reimbursement Scenario

7.2. Europe

7.2.1. Germany

7.2.1.1. Germany Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.1.2. Market Dynamics

7.2.1.3. Competitive Landscape

7.2.1.4. Regulatory Framework

7.2.1.5. Reimbursement Scenario

7.2.2. U.K.

7.2.2.1. UK Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.2.2. Market Dynamics

7.2.2.3. Competitive Landscape

7.2.2.4. Regulatory Framework

7.2.2.5. Reimbursement Scenario

7.2.3. France

7.2.3.1. France Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.3.2. Market Dynamics

7.2.3.3. Competitive Landscape

7.2.3.4. Regulatory Framework

7.2.3.5. Reimbursement Scenario

7.2.4. Italy

7.2.4.1. Italy Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.4.2. Market Dynamics

7.2.4.3. Competitive Landscape

7.2.4.4. Regulatory Framework

7.2.4.5. Reimbursement Scenario

7.2.5. Spain

7.2.5.1. Spain Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.5.2. Market Dynamics

7.2.5.3. Competitive Landscape

7.2.5.4. Regulatory Framework

7.2.5.5. Reimbursement Scenario

7.2.6. Sweden

7.2.6.1. Sweden Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.6.2. Market Dynamics

7.2.6.3. Competitive Landscape

7.2.6.4. Regulatory Framework

7.2.6.5. Reimbursement Scenario

7.2.7. Norway

7.2.7.1. Norway Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.7.2. Market Dynamics

7.2.7.3. Competitive Landscape

7.2.7.4. Regulatory Framework

7.2.7.5. Reimbursement Scenario

7.2.8. Denmark

7.2.8.1. Denmark Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.8.2. Market Dynamics

7.2.8.3. Competitive Landscape

7.2.8.4. Regulatory Framework

7.2.8.5. Reimbursement Scenario

7.2.9. Switzerland

7.2.9.1. Switzerland Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.9.2. Market Dynamics

7.2.9.3. Competitive Landscape

7.2.9.4. Regulatory Framework

7.2.9.5. Reimbursement Scenario

7.2.10. Netherlands

7.2.10.1. Netherlands Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.10.2. Market Dynamics

7.2.10.3. Competitive Landscape

7.2.10.4. Regulatory Framework

7.2.10.5. Reimbursement Scenario

7.2.12. Rest of Europe

7.2.11.1. Rest of Europe Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.2.11.2. Market Dynamics

7.2.11.3. Competitive Landscape

7.2.11.4. Regulatory Framework

7.2.11.5. Reimbursement Scenario

7.3. Asia Pacific

7.3.1. China

7.3.1.1. China Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.1.2. Market Dynamics

7.3.1.3. Competitive Landscape

7.3.1.4. Regulatory Framework

7.3.1.5. Reimbursement Scenario

7.3.2. Japan

7.3.2.1. Japan Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.2.2. Market Dynamics

7.3.2.3. Competitive Landscape

7.3.2.4. Regulatory Framework

7.3.2.5. Reimbursement Scenario

7.3.3. India

7.3.3.1. India Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.3.2. Market Dynamics

7.3.3.3. Competitive Landscape

7.3.3.4. Regulatory Framework

7.3.3.5. Reimbursement Scenario

7.3.4. Australia

7.3.4.1. Australia Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.4.2. Market Dynamics

7.3.4.3. Competitive Landscape

7.3.4.4. Regulatory Framework

7.3.4.5. Reimbursement Scenario

7.3.5. South Korea

7.3.5.1. South Korea Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.5.2. Market Dynamics

7.3.5.3. Competitive Landscape

7.3.5.4. Regulatory Framework

7.3.5.5. Reimbursement Scenario

7.3.6. Thailand

7.3.6.1. Thailand Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.6.2. Market Dynamics

7.3.6.3. Competitive Landscape

7.3.6.4. Regulatory Framework

7.3.6.5. Reimbursement Scenario

7.3.7. Indonesia

7.3.7.1. Indonesia Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.7.2. Market Dynamics

7.3.7.3. Competitive Landscape

7.3.7.4. Regulatory Framework

7.3.7.5. Reimbursement Scenario

7.3.8. Rest of Asia Pacific

7.3.8.1. Rest of Asia Pacific Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.3.8.2. Market Dynamics

7.3.8.3. Competitive Landscape

7.3.8.4. Regulatory Framework

7.3.8.5. Reimbursement Scenario

7.4. Latin America

7.4.1. Brazil

7.4.1.1. Brazil Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.1.2. Market Dynamics

7.4.1.3. Competitive Landscape

7.4.1.4. Regulatory Framework

7.4.1.5. Reimbursement Scenario

7.4.2. Mexico

7.4.2.1. Mexico Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.2.2. Market Dynamics

7.4.2.3. Competitive Landscape

7.4.2.4. Regulatory Framework

7.4.2.5. Reimbursement Scenario

7.4.3. Argentina

7.4.3.1. Argentina Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.3.2. Market Dynamics

7.4.3.3. Competitive Landscape

7.4.3.4. Regulatory Framework

7.4.3.5. Reimbursement Scenario

7.4.4. Colombia

7.4.4.1. Colombia Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.4.4.2. Market Dynamics

7.4.4.3. Competitive Landscape

7.4.4.4. Regulatory Framework

7.4.4.5. Reimbursement Scenario

7.5. Middle East and Africa

7.5.1. South Africa

7.5.1.1. South Africa Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.1.2. Market Dynamics

7.5.1.3. Competitive Landscape

7.5.1.4. Regulatory Framework

7.5.1.5. Reimbursement Scenario

7.5.2. Saudi Arabia

7.5.2.1. Saudi Arabia Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.2.2. Market Dynamics

7.5.2.3. Competitive Landscape

7.5.2.4. Regulatory Framework

7.5.2.5. Reimbursement Scenario

7.5.3. UAE

7.5.3.1. UAE Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.3.2. Market Dynamics

7.5.3.3. Competitive Landscape

7.5.3.4. Regulatory Framework

7.5.3.5. Reimbursement Scenario

7.5.4. Kuwait

7.5.4.1. Kuwait Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.4.2. Market Dynamics

7.5.4.3. Competitive Landscape

7.5.4.4. Regulatory Framework

7.5.4.5. Reimbursement Scenario

7.5.5. Rest of Middle East and Africa

7.5.5.1. Rest of MEA Plaque Modification Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.5.5.2. Market Dynamics

7.5.5.3. Competitive Landscape

7.5.5.4. Regulatory Framework

7.5.5.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. 3M Abbott Laboratories

8.5.2. Acotec Scientific Holdings Limited

8.5.3. Asahi Intecc Co., Ltd.

8.5.4. BIOTRONIK SE & Co. KG

8.5.5. Boston Scientific Corporation

8.5.6. Cardiovascular Systems, Inc. (Abbott)

8.5.7. C. R. Bard, Inc. (BD)

8.5.8. Koninklijke Philips N.V.

8.5.9. Medtronic plc

8.5.10. Merit Medical Systems, Inc.

8.5.11. Penumbra, Inc.

8.5.12. Shockwave Medical, Inc. (Johnson & Johnson)

8.5.13. Straub Medical AG

8.5.14. Terumo Corporation

8.5.15. Teleflex Incorporated

8.5.16. W. L. Gore & Associates, Inc.

9. Analyst Perspective

10. Related Reports

Related Research

Blood Clot Retrieval Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Radiofrequency Skin Rejuvenation Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Dental Splints Market Revenue & Forecast Analysis, 2026-2035

July 13, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.